Survival and functional restoration of human fetal ventral mesencephalon following transplantation in a rat model of parkinson's disease

Cell Transplantation

Volumn 22, Issue 7, 2013, Pages 1281-1293

  Rath, Anika ^a   Klein, Alexander ^b   Papazoglou, Anna ^a   Pruszak, Jan ^a   Garcia, Joanna ^a   Krause, Martin ^a   Maciaczyk, Jaroslaw ^a   Dunnett, Stephen B ^b   Nikkhah, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Glass capillary; Metal cannula; Neurorestoration; Single cell suspension; Tissue pieces

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL SUSPENSION; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FETUS; GRAFT SURVIVAL; HUMAN; HUMAN CELL; MESENCEPHALON; NERVE FIBER GROWTH; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TISSUE SECTION;

ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; GRAFT SURVIVAL; HUMANS; MESENCEPHALON; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; TRANSPLANTATION, HETEROLOGOUS; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 84879592205     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X654984     Document Type: Article

References (55)

1. Abercrombie, M. Estimation of nuclear population from microtome sections. Anat. Rec. 94:239-247; 1946.
2. Baker, K. A.; Sadi, D.; Hong, M.; Mendez, I. Simultaneous intrastriatal and intranigral dopaminergic grafts in the Parkinsonian rat model: Role of the intranigral graft. J. Comp Neurol. 426:106-116; 2000.
3. Barker, R. A.; Fricker, R. A.; Abrous, D. N.; Fawcett, J.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of nigral grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant. 4:173-200; 1995.
4. Bentlage, C.; Nikkhah, G.; Cunningham, M. G.; Bjorklund, A. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp. Neurol. 159:177-190; 1999.
5. Bjorklund, A.; Stenevi, U.; Schmidt, R. H.; Dunnett, S. B.; Gage, F. H. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 522:1-7; 1983.
6. Boer, G. J. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR). J. Neurol. 242:1-13; 1994.
7. Brundin, P.; Karlsson, J.; Emgard, M.; Schierle, G. S.; Hansson, O.; Petersen, A.; Castilho, R. F. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant. 9:179-195; 2000.
8. Brundin, P.; Nilsson, O. G.; Gage, F. H.; Bjorklund, A. Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp. Brain Res. 60:204-208; 1985.
9. Brundin, P.; Nilsson, O. G.; Strecker, R. E.; Lindvall, O.; Astedt, B.; Bjorklund, A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res. 65:235-240; 1986.
10. Brundin, P.; Strecker, R. E.; Widner, H.; Clarke, D. J.; Nilsson, O. G.; Astedt, B.; Lindvall, O.; Bjorklund, A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp. Brain Res. 70:192-208; 1988.
11. Brundin, P.; Widner, H.; Nilsson, O. G.; Strecker, R. E.; Bjorklund, A. Intracerebral xenografts of dopamine neurons: The role of immunosuppression and the blood-brain barrier. Exp. Brain Res. 75:195-207; 1989.
12. Cheramy, A.; Leviel, V.; Glowinski, J. Dendritic release of dopamine in the substantia nigra. Nature 289:537-542; 1981.
13. Clarke, D. J.; Brundin, P.; Strecker, R. E.; Nilsson, O. G.; Bjorklund, A.; Lindvall, O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73:115-126; 1988.
14. Deacon, T.W.; Pakzaban, P.; Burns, L.H.; Dinsmore, J.; Isacson, O. Cytoarchitectonic development, axon-glia relationships, and long distance axon growth of porcine striatal xenografts in rats. Exp. Neurol. 130(1):151-167; 1994.
15. Dunnett, S. B. Motor Function(s) of the nigrostriatal dopamine system: Studies of lesions and behavior. In: Dunnett, S. B.; Bentivogolio, M.; Bjorklund, A.; Hokfelt, T., eds. Dopamine. Amsterdam, Netherlands: Elsevier; 2005:237-302.
16. Dunnett, S. B.; Bjorklund, A. Transplantation of dopamine neurons: Extent and mechanisms of functional recovery in rodent models of Parkinson's disease. In: Iversen, L. L.; Iversen, S. D.; Dunnett, S. B.; Bjorklund, A., eds. Dopamine Handbook. New York City, USA: Oxford University Press; 2010:454-477.
17. Dunnett, S. B.; Bjorklund, A.; Schmidt, R. H.; Stenevi, U.; Iversen, S. D. Intracerebral grafting of neuronal cell suspensions. IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sites. Acta Physiol. Scand. Suppl. 522:29-37; 1983.
18. Freed, C. R.; Greene, P. E.; Breeze, R. E.; Tsai, W. Y.; DuMouchel, W.; Kao, R.; Dillon, S.; Winfield, H.; Culver, S.; Trojanowski, J. Q.; Eidelberg, D.; Fahn, S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344:710-719; 2001.
19. Gaillard, A.; Decressac, M.; Frappe, I.; Fernagut, P. O.; Prestoz, L.; Besnard, S.; Jaber, M. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants. Neurobiol. Dis. 35:477-488; 2009.
20. Isacson, O.; Deacon, T. Neural transplantation studies reveal the brain's capacity for continuous reconstruction. Trends Neurosci. 20(10):477-482; 1997.
21. Isacson, O.; Deacon, T. W.; Pakzaban, P.; Galpern, W. R.; Dinsmore, J.; Burns, L. H. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1(11):1189-1194; 1995.
22. Jackson, E. A.; Kelly, P. H. Nigral dopaminergic mechanisms in drug-induced circling. Brain Res. Bull. 11:605-611; 1983.
23. Kelly, C. M.; Precious, S. V.; Penketh, R.; Amso, N.; Dunnett, S. B.; Rosser, A. E. Striatal graft projections are influenced by donor cell type and not the immunogenic background. Brain 130:1317-1329; 2007.
24. Kelly, C. M.; Precious, S. V.; Torres, E. M.; Harrison, A. W.; Williams, D.; Scherf, C.; Weyrauch, U. M.; Lane, E. L.; Allen, N. D.; Penketh, R.; Amso, N. N.; Kemp, P. J.; Dunnett, S. B.; Rosser, A. E. Medical terminations of pregnancy: A viable source of tissue for cell replacement therapy for neurodegenerative disorders. Cell Transplant. 20:503-513; 2011.
25. Klein, A.; Metz, G. A.; Papazoglou, A.; Nikkhah, G. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol. Dis. 27:24-35; 2007.
26. Kozlowski, M. R.; Sawyer, S.; Marshall, J. F. Behavioural effects and supersensitivity following nigral dopamine receptor stimulation. Nature 287:52-54; 1980.
27. Lane, E. L.; Bjorklund, A.; Dunnett, S. B.; Winkler, C. Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia. Prog. Brain Res. 184:295-309; 2010.
28. Lindvall, O. Clinical experiences with dopamine neuron replacement in Parkinson's disease: What is the future? In: Iversen, L. L.; Iversen, S. D.; Dunnett, S. B.; Bjorklund, A., eds. Dopamine Handbook. New York City, USA: Oxford University Press; 2010:478-488.
29. Mendez, I.; Dagher, A.; Hong, M.; Gaudet, P.; Weerasinghe, S.; McAlister, V.; King, D.; Desrosiers, J.; Darvesh, S.; Acorn, T.; Robertson, H. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases. J. Neurosurg. 96:589-596; 2002.
30. Nelander, J.; Hebsgaard, J. B.; Parmar, M. Organization of the human embryonic ventral mesencephalon. Gene Expr. Patterns 9:555-561; 2009.
31. Nikkhah, G.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci. 14:3449-3461; 1994.
32. Nikkhah, G.; Cunningham, M. G.; Cenci, M. A.; McKay, R. D.; Bjorklund, A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J. Neurosci. 15:3548-3561; 1995.
33. Nikkhah, G.; Cunningham, M. G.; Jodicke, A.; Knappe, U.; Bjorklund, A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633:133-143; 1994.
34. Nikkhah, G.; Olsson, M.; Eberhard, J.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology. Neuroscience 63:57-72; 1994.
35. Nikkhah, G.; Rosenthal, C.; Falkenstein, G.; Roedter, A.; Papazoglou, A.; Brandis, A. Microtransplantation of dopaminergic cell suspensions: Further characterization and optimization of grafting parameters. Cell Transplant. 18:119-133; 2009.
36. Olanow, C. W.; Goetz, C. G.; Kordower, J. H.; Stoessl, A. J.; Sossi, V.; Brin, M. F.; Shannon, K. M.; Nauert, G. M.; Perl, D. P.; Godbold, J.; Freeman, T. B. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54:403-414; 2003.
37. Redmond, Jr., D. E.; Elsworth, J. D.; Roth, R. H.; Leranth, C.; Collier, T. J.; Blanchard, B.; Bjugstad, K. B.; Samulski, R. J.; Aebischer, P.; Sladek, Jr., J. R. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J. Comp. Neurol. 515(1):31-40; 2009.
38. Redmond, Jr., D. E.; Vinuela, A.; Kordower, J. H.; Isacson, O. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiol. Dis. 29:103-116; 2008.
39. Robertson, G. S.; Fine, A.; Robertson, H. A. Dopaminergic grafts in the striatum reduce D1 but not D2 receptormediated rotation in 6-OHDA-lesioned rats. Brain Res. 539:304-311; 1991.
40. Robertson, G. S.; Robertson, H. A. Evidence that L-dopainduced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9:3326-3331; 1989.
41. Strömberg, I.; Adams, C.; Bygdeman, M.; Hoffer, B.; Boyson, S.; Humpel, C. Long-term effects of human-to-rat mesencephalic xenografts on rotational behavior, striatal dopamine receptor binding, and mRNA levels. Brain Res. Bull. 38(3):221-233; 1995.
42. Strömberg, I.; Almqvist, P.; Bygdeman, M.; Finger, T. E.; Gerhardt, G.; Granholm, A. C.; Mahalik, T. J.; Seiger, A.; Olson, L.; Hoffer, B. Human fetal mesencephalic tissue grafted to dopamine-denervated striatum of athymic rats: Light- and electron-microscopical histochemistry and in vivo chronoamperometric studies. J. Neurosci. 9(2):614-624; 1989.
43. Strömberg, I.; Bickford, P.; Gerhardt, G. A. Grafted dopamine neurons: Morphology, neurochemistry, and electrophysiology. Prog. Neurobiol. 90(2):190-197; 2010.
44. Strömberg, I.; Bygdeman, M.; Goldstein, M.; Seiger, A.; Olson, L. Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: Evidence for functional reinnervation. Neurosci. Lett. 71(3): 271-276; 1986.
45. Strömberg, I.; Törnqvist, N.; Johansson, S.; Bygdeman, M.; Almqvist, P. M. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons. Microsc. Res. Tech. 54(5):287-297; 2001.
46. Thompson, L. H.; Grealish, S.; Kirik, D.; Bjorklund, A. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur. J. Neurosci. 30:625-638; 2009.
47. Torres, E. M.; Dowd, E.; Dunnett, S. B. Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson's disease. Neuroscience 154:631-640; 2008.
48. Ungerstedt, U.; Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24:485-493; 1970.
49. Wictorin, K.; Brundin, P.; Gustavii, B.; Lindvall, O.; Björklund, A. Reformation of long axon pathways in adult rat central nervous system by human forebrain neuroblasts. Nature 347(6293):556-558; 1990.
50. Wictorin, K.; Brundin, P.; Sauer, H.; Lindvall, O.; Bjorklund, A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 323:475-494; 1992.
51. Wictorin, K.; Clarke, D. J.; Bolam, J. P.; Brundin, P.; Gustavii, B.; Lindvall, O.; Bjorklund, A. Extensive efferent projections of intra-striatally transplanted striatal neurons as revealed by a species-specific neurofilament marker and anterograde axonal tracing. Prog. Brain Res. 82:391-399; 1990.
52. Winkler, C.; Bentlage, C.; Nikkhah, G.; Samii, M.; Bjorklund, A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp. Neurol. 155:165-186; 1999.
53. Winkler, C.; Kirik, D.; Bjorklund, A. Cell transplantation in Parkinson's disease: How can we make it work? Trends Neurosci. 28:86-92; 2005.
54. Zetterstrom, T.; Sharp, T.; Marsden, C. A.; Ungerstedt, U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: Changes after d-amphetamine. J. Neurochem. 41:1769-1773; 1983.
55. Zigmond, M. J.; Berger, T. W.; Grace, A. A.; Stricker, E. M. Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of Parkinsonism. Mol. Chem. Neuropathol. 10:185-200; 1989.